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Resumo 
Introdução: A capacidade funcional e a qualidade de vida são medidas do estado de saúde do doente 
com insuficiência cardíaca (IC) e podem demonstrar o impacto da doença na capacidade de realizar 
atividades da vida diária (AVD´s). O teste Glittre-ADL (TGlittre) foi criado para avaliar a capacidade 
funcional em doentes, baseando-se nas atividades da vida diária. As respostas fisiológicas deste teste em 
doentes com IC ainda são desconhecidas. Objectivo(s): Analisar e comparar o desempenho cardíaco, 
ventilatório e metabólico no TGlittre, na prova de marcha de 6 minutos (PM6M) e na prova de esforço 
cardiopulmonar (PECP) em doentes com IC. Métodos: Estudo prospectivo e transversal com 11 doentes 
de ambos os sexos, com uma mediana 65 anos, com IC (mediana da fração de ejeção do ventriculo 
esquerdo de 40%) submetidos a avaliações antropométricas, função pulmonar e realizaram uma PECP, o 
TGlittre e PM6M. Resultados: As variáveis cardiopulmonares basais foram semelhantes entre o TGlittre 
e a PM6M (p>0,05). O TGlittre induziu um VE, VE/VO2, RER, FC e VE/MVV significativamente 
superior em relação à PM6M (p<0,05). As outras variáveis fisiológicas obtidas foram semelhantes em  
ambos os testes. O TGlittre apresentou uma correlação significativa com a distância na PM6M (r=-0,64; 
p=0,04). No consumo final de oxigénio (VO2), o TGlittre apresentou uma correlação significativa com a 
PECP (r=0,72; p=0,01) e com a PM6M (r=0,67; p=0,02). O TGlittre apresenta caracteristicas 
submáximas quando comparado com a PECP. Conclusão: O TGlittre induziu respostas ventilatórias e 
cardiovasculares superiores comparativamente com a PM6M, com perfil metabólico semelhante.  
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Abstract 
Background: Functional capacity and quality of life are measures of the heart failure (HF) patient’s 
health status and can demonstrate the impact of the disease on the ability to perform activities of daily 
living (ADL´s). The Glittre-ADL (TGlittre) test is supposed to evaluate patient´s functional capacity and 
their ability to perform activities of daily life. The physiological requirements of this test in HF patients 
are still unknown. 
Aim(s): Analyze and compare the cardiac, ventilatory and metabolic performance of the TGlittre, 6 
minute walk test (6MWT) and cardiopulmonary exercise test (CPET) in patients with HF. Methods: A 
prospective cross-sectional study with 11 patients of both genders (median age of 65) with HF (median 
left ventricle ejection fraction of 40%) underwent anthropometric and lung function assessments and were 
submitted to a CPET. In separate day, with a maximum of 10 days apart, patients performed the TGlittre 
and 6MWT. Results: Baseline cardiopulmonary variables were similar between TGlittre and 6MWT 
(p>0,05). TGlittre induce significantly higher VE, VE/VO2, RER, HR and VE/MVV (p<0,05) compared 
to 6MWT. The other physiological variables were similar at the end of both tests. TGlittre showed a 
significant correlation with 6MWT distance (r=-0,64; p=0,04). In the final oxygen consumption (VO2), 
TGlittre showed a significant correlation with CPET (r=0,72; p=0,01) and 6MWT (r=0,67; p=0,02). 
TGlittre showed submaximal characteristics when compared with the CPET. Conclusion: TGlittre induce 
higher ventilatory and cardiovascular responses than the 6MWT, with similar metabolic adjustments.  
  
Key words: heart failure, TGlittre, activities of daily living, functional capacity 
  
1. Introduction 
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood 
vessels, caused by the interaction of genetic and environmental factors. They are 
considered a public health problem and have a negative impact on patient’s quality of 
life. The most prevalent CVDs are hypertension, coronary artery disease and heart 
failure (HF)  (Greenland et al., 2010; Smith et al., 2013). 
 HF is a clinical syndrome characterized by typical symptoms, (e.g. exertional 
dyspnea) caused by a structural and/or functional cardiac abnormality, resulting in a 
reduced cardiac output and/ or elevated intracardiac pressures at rest or during stress 
(Ponikowski et al., 2016). 
 The assessment of functional capacity in patients with HF is important for 
clinical practice because it helps to understand patient’s limitations and their impact on 
quality of life to prognosticate and to tailor treatment (Fernandes-Andrade, Britto, 
Soares, Velloso, & Pereira, 2017). 
Although cardiopulmonary exercise testing (CPET) is considered the gold 
standard for evaluation of functional capacity, it is not feasible or adequate in many  
frail and functionally impaired patients referred to cardio-respiratory rehabilitation 
programs (Forman et al., 2017). Therefore, submaximal tests, such as the 6-minute walk 
test (6MWT), have been widely used to assess functional capacity and to target 
intervention outcomes. 
On the other hand, it is well known that patients with HF experience impairment 
in the ability to carry out activities of daily living (ADLs). The capacity to perform 
ADLs will be the most important factor on patient's functional independence, ability to 
work or to be safe on a day-to-day basis than maximal exercise tolerance (Forman et al., 
2017; Kaminsky & Tuttle, 2014). Even knowing that 6MWT is a functional test used to 
evaluate the ability of patients perform ADLs, it´s an exclusive gait test, not being 
specific to evaluate activities that use the upper and lower limbs simultaneously 
(Skumlien, Hagelund, Bjørtuft, & Ryg, 2006). It´s well known that the use of the upper 
limbs is an important component in the execution of ADLs, which are guided reaching, 
grip and object handling (Rosamond et al., 2008). 
 Thus, considering that assessment of the functional capacity of CVDs patients 
should include the upper and lower limbs, there is a need for a comprehensive test that 
captures the patients’ limitations to perform daily lives tasks (Fernandes-Andrade et al., 
2017). 
The Glittre–Activities of Daily Living Test (TGlittre) is a field test developed 
and validated to measure the functional capacity of patients with chronic obstructive 
pulmonary disease (COPD), through the most relevant issues of the pulmonary 
functional status and dyspnea questionnaire, which include day-to-day activities such as 
walking, sitting and standing, climbing stairs and moving objects with upper limbs 
(Skumlien et al., 2006). 
It is still necessary to prove TGlittre validity in the evaluation and rehabilitation 
treatment response in individuals with HF, taking into account that little data is 
available of this stress testing, as well as on its utility as efficacy benchmark for cardio-
respiratory rehabilitation programs. Despite of the physiological demands by the 
TGlittre on patients with HF is still unknown, we hypothesized that might be different 
from that induce by the 6MWT. 
Therefore, the purpose of this study is to compare the cardiac, ventilatory and 
metabolic performance of the TGlittre and 6MWT of patients with HF who also 
underwent a CPET.  
 
2. Methods 
2.1. Study Design 
This study is characterized as a prospective cross-sectional study.  
 
2.2. Subjects 
The target population included patients with a diagnosis of HF with age equal to or 
greater than 18 years, referred to cardiorespiratory rehabilitation program in Centro 
Reabilitação do Norte – Dr. Ferreira Alves, Vila Nova de Gaia. 
Patients with unstable angina, decompensated heart failure or complex 
ventricular arrhythmias, with inability to perform physical exercise (eg. osteoarticular 
pathology) and with chronic obstructive pulmonary disease (COPD) defined by FEV1 / 
FVC ratio <0.7 were excluded from the study. 
A convenience sample was used and 14 HF patients attending the Centro de 
Reabilitação do Norte agreed to participate in our study. Of these, 2 were excluded 
because technical problems with evaluation instruments and 1 due to withdrawal during 
collection. Finally, the final sample consisted of 11 patients (Figure 1). 
  
 
 
 
 
 
 
 
 
 
Figure 1 - Sample constitution diagram. 
 
2.3. Instruments 
2.3.1. Sample Characterization 
The characterization of the sample was performed based on an interview about 
sociodemographic data (age and gender). The clinical process was used to obtain the 
values of left ventricle ejection fraction (LVEF) and New York Heart Association 
Functional Classification (NYHA). 
Anthropometric measures were evaluated through a SECA 220 stadiometer 
(SECA - Medical Scales and Measuring Systems®, Hamburg, Germany), with an 
accuracy of ± 5mm, and SECA 769 scale, with precision of 100 g (SECA - Medical 
Scales and Measuring Systems®, Hamburg, Germany), respectively. 
 
2.3.2. Cardiopulmonary Exercise Test (CPET) 
The CPET provides information on the response of the human body to exercise, through 
breath-by-breath gas exchange measures, during a progressive intensity exercise 
stimulus to provide an integrated analysis of physiological responses required by 
cardiovascular and respiratory systems to meet the metabolic demands of the skeletal 
muscle (Malhotra, Bakken, D’Elia, & Lewis, 2016).  
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2.3.3. Glittre-ADL Test(TGlittre) 
TGlittre was developed with the objective of evaluate the functional status through daily 
activities, such as walking, getting up and sitting, going up and down stairs and moving 
objects at different heights in individuals with COPD (Skumlien et al., 2006).  
 
2.3.4. 6 Minute Walk Test (6MWT) 
6MWT is a simple, low cost and practical measure of exercise capacity. It is a widely 
used and standardized evaluation in several scenarios, including people with 
cardiopulmonary diseases, with significant prognostic value (Holland et al., 2014; ATS, 
2002).  
 
2.3.5. Physiological Responses 
In order to evaluate the physiological responses, patients were connected to a telemetric 
portable gas analyzer (K4b
2
, Cosmed®, Rome, Italy). The K4b
2
 is a light device with a 
face mask, heart rate chest strip, battery, a portable transmitting unit and was calibrated 
according to the manufacturer´s recommendations – volume calibration; room air 
calibration; reference gas calibration and delay calibration. The following variables 
were measured on a breath-by-breath mode: oxygen uptake (VO2), carbon dioxide 
output (VCO2 ), respiratory rate (RR), minute volume (VE), respiratory exchange rate 
(RER), heart rate (HR), oxygen pulse (VO2/HR), ventilatory demand (VE/MVV), and 
ventilatory equivalent for oxygen uptake and carbon dioxide output (VE/VO2 and 
VE/VCO2) (Tufanin et al., 2014). Maximum Voluntary Ventilation (MVV) was 
calculated based on the equation: FEV1 × 40. 
 
2.4. Study Protocol 
Evaluations were completed in two nonconsecutive days. On the first day, 
anthropometric and lung function assessments were carried out for all subjects. Then, 
patients performed a CPET on treadmill, fulfilling the Bruce protocol, whereby patients 
start exercising at 2.7 km/h on a 10% grade. Every 3 minutes the speed and grade 
increase to a maximum of 9,6 km/h and 22% grade (Bruce, Blackmon, Jones, & Strait, 
2004). Subjects were encouraged to continue the exercise until exhaustion, but it could 
be interrupted in case of limiting symptoms. On the same day, patients underwent a 
familiarization trial for both 6MWT and TGlittre.   
On the second day, within a ten days period, 6MWT and TGlittre were 
performed, randomly, with a minimum of 30 minutes resting time or the necessary time 
for all physiologic parameters return to basal values. During both functional capacity 
tests patients were connected to a telemetric portable gas analyzer to evaluate 
physiological responses. 
In the 6MWT, performed according to the guidelines of American Thoracic 
Society, patients were asked to walk as far as possible, in 6 minutes, along a flat 
corridor of 30 meters demarcated every 3 meters. Standardized instructions and 
encouragement were given during the test. If the patient needed to stop walking during 
the test, the timer wasn´t stopped. Peripheral oxygen saturation (SpO2), Heart Rate and 
Borg score for exertion, dyspnea and blood pressure were measured at the beginning 
and end of the test. The total distance walked by the patient, corresponds to the main 
outcome measure  (Crapo et al., 2002; Holland et al., 2014).  
The TGlittre test started with the patient rising from a seated position. Then, 
patients had to walk along a 10 meters flat course, going up and down 2 steps (17cm 
high and 27cm wide) located in the middle of the course, face two shelves upon arrival 
at the end of the course adjusted to patients’ shoulder and waist height. Three jars of 
1kg each, were positioned on the top shelf and the patient had to move them, one at a 
time, to the bottom shelf, and then to the floor. Afterwards, the patients returned the 
pots to the bottom shelf and then back to the top shelf. The patients then turned and 
walk back over the stairs to the chair, sat down, and immediately started the next lap. 
The test ends after five laps. The entire course was made wearing a schoolbag weighing 
2.5kg (women) or 5.0kg (men).  
Prior to the test, patients were oriented to perform it the fastest they could 
without running and no verbal incentive was given during the test. Patients are allowed 
to rest, if necessary, but their goal is to perform the test as quick as possible. If the 
patient stopped to rest, the chronometer went on counting the time. The test´s outcome 
was the total time taken to complete all the five laps (Tufanin et al., 2014). Before and 
at the end of the test, SpO2, HR, Borg score for exertion and dyspnea and blood 
pressure were measured. The criteria for interruption were SpO2 below 80%, HR above 
85% of  maximum HR predicted by Astrand formula (220-age), chest pain, dizziness, 
nausea, and headache (Tufanin et al., 2014). 
 
  
2.5. Ethic 
The study was approved by the Board of Administration and the Ethics Committee of 
the Santa Casa da Misericórdia do Porto.  
Participants were informed of the study objectives, principles and possible 
implications of data collection methods and procedures for the analysis and treatment of 
collected information. They were also given the opportunity to ask any questions that 
they deemed necessary, as well as to refuse to participate in the study or to interrupt it at 
any time. 
Participants agreed to join the study by signing the Helsinki Declaration, and the 
anonymity and confidentiality of the data were maintained throughout the study. 
 
2.6. Statistical analysis 
We opted for using non-parametric inferential statistics due to the reduced sample 
number (Marôco, 2010). 
 The measures of central tendency and dispersion were used to the descriptive 
statistics regarding the characterization of the sample. 
 The Wilcoxon signed-rank test was used to compare physiological data between 
6MWT and TGlittre.  Correlations between hemodynamic and metabolic variables were 
determined using Spearman´s correlation test.  The existence of weak linear correlation 
was considered for a correlation coefficient between 0 and 0.3, moderate between 0.3 
and 0.6, strong between 0.6 and 0.9 and very strong between 0.9 and 1. Statistical 
significance was determined by p < 0,05 (Marôco, 2010). Statistical analysis was 
performed using SPSS Statistics 25.0 (Statistical Package for the Social Sciences®). 
 
2.7. Results 
The final study sample consisted of 11 patients (2 females), with NYHA between class I 
(18%), II (73%) and III (9%). All 11 patients were able to finish the CPET, 6MWT and 
TGlittre without any intercurrence. The anthropometric parameters, pulmonary and 
cardiac function data are demonstrated in Table 1. 
 
 
 
 
Table 1: Characteristics of the study group 
Characteristics Median IQR 25/75 Minimum Maximum 
Age (years) 65,00 55,00 / 75,00 37,00 81,00 
Weight (kg) 78,00 69,00 / 80,00 62,00 101,00 
Height (m) 1,69 1,60 / 1,71 1,46 1,75 
BMI (kg/m
2
) 28,07 26,36 / 30,85 20,24 32,98 
LVEF (%) 40,00 35,00 / 42,00 26,00 60,00 
FVC (L) 3,30 2,65 / 3,66 1,90 4,76 
FEV1 (L) 2,58 2,2 / 2,73 1,53 3,95 
IQR: interquartile range; BMI: body mass index; LVEF: left ventricle ejection fraction; FVC: forced vital 
capacity; FEV1: forced expiratory volume in 1 second. 
 
All the physiological variables measured at CPET are shown in Table 2.  
 
Table 2 – Cardiopulmonary exercise test results of the study group 
 Median IQR 25/75 
SBP, mmHg 140 140 / 160 
DBP, mmHg 70 70 / 90 
RR, bpm 34 28 / 35 
VE, L 50 45 / 70 
VO2, ml/min 1290 1050 / 1790 
VO2/Kg, ml/min/kg 17 14 / 20,1 
VCO2, ml/min 1250 990 / 2040 
VE/VO2 42,8 3,5 / 45,9 
VE/VCO2 37,4 33,9 / 39,2 
RER 1,12 1 / 1,14 
HR, bpm 112 105 / 123 
O2 pulse, VO2/HR 11,8 9 / 13,6 
VE/MVV 0,56 0,48 / 0,64 
IQR: interquartile range; SBP: systolic blood pressure; DBP: diastolic blood pressure; RR: 
respiratory rate; VT: tidal volume; VE: minute ventilation; VO2: oxygen uptake; VCO2: 
carbon dioxide output; VE/VO2: ventilatory equivalent for oxygen; VE/VCO2: ventilatory 
equivalent for carbon dioxide; RER: respiratory exchange ratio; HR: hear rate; MVV: 
maximal voluntary ventilation. 
 
Baseline cardiopulmonary variables were similar between the 6MWT and TGlittre 
(p>0,05). The variables VE, VE/VO2, RER, HR and VE/MVV were significantly higher 
in the end of TGlittre. On the contrary, the variable VO2/HR was significantly higher on 
6MWT. All the physiological variables measured at 6MWT and TGlittre are shown in 
Table 3. 
 
Table 3: Comparison between functional capacity tests  
  
Rest  Finalª 
6MWT TGlittre   
 
6MWT (6min) TGlittre (5ºlap)   
Median [IQR] Median [IQR] p-value  Median [IQR] Median [IQR] p-value 
SBP, mmHg 119 [115-135] 121 [114-133] 0,61  133 [131- 153] 138 [131- 153] 0,16 
DBP, mmHg 73 [70/ 77] 71 [71-76] 0,95  75 [70-93] 76 [70-85] 0,79 
RR, bpm 
17,92 [15,35-
20,62] 
18,03 [16,80-
23,03] 0,92 
 26,35 [22,81-
36,35] 
29,42 [26,50-
38,92] 0,21 
VT, L 0,76 [0,54-0,86] 
0,67 [0,57-
0,83] 0,09 
 1,56 [1,28-
1,65] 
1,56 [1,07-
1,84] 0,62 
VE, L/min 
14,95 [10,74-
15,99] 
11,92 [10,91-
14,85] 0,12 
 40,49 [35,92-
44,15] 
45,82 [43,36-
50,75] 0,03 
VO2, ml/min 
351,81 [323,35-
455,46] 
317,56 
[234,08-
357,03] 0,11 
 1239,84 
[1044,32-
1448,45] 
1104,96 
[876,42-
1356,55] 0,42 
VO2/kg, 
ml/min/kg 4,84 [4,09-5,62] 
4,15 [3,77-
4,57] 0,11 
 16,10 [14,04-
17,43] 
15,57 [11,43-
17,82] 0,31 
VCO2, 
ml/min 
281,39 [253,43-
362,39] 
271,78 
[231,82-
320,15] 0,24 
 1011,27 
[894,01-
1155,22] 
1083,72 
[1028,07-
1258,41] 0,09 
VE/VO2 
35,28 [30,99-
48,70] 
39,80 [36,70-
46,60] 0,42 
 34,39 [27,46-
39,88] 
36,93 [32,19-
49,05] 0,01 
VE/VCO2 
47,33 [41,48-
50,88] 
45,43 [44,23-
49,56] 0,68 
 38,24 [34,19-
46,31] 
38,28 [34,48-
43,63] 0,47 
RER 
0,83 (0,73/ 
0,98) 
0,91 
(0,82/0,92) 0,59 
 0,82 (0,73/ 
0,89) 
0,97 
(0,86/1,17) 0,04 
HR, bpm 
63,66 
(56/72,71) 
58,50 ( 55,29/ 
77,14) 0,24 
 94 (87,31/ 
110,23) 
101 
(94,42/119,71) 0,01 
O2 pulse, 
VO2/HR 
5,77 (4,58/ 
6,54) 
5,75 ( 3,66/ 
6,14) 0.21 
 12,28 (10,52/ 
14,25) 
11,23 (8,08/ 
13,98) 0,04 
VE/MVV 0,14 (0,09/0,17) 0,14(0,09/0,16) 0,26 
 0,41 
(0,34/0,48) 
0,45 
(0,38/0,58) 0,03 
ªFinal values refer to the average of the last 15 seconds of both the last minute of 6MWT (6
th
 minute) and 
the last lap of TGlittre (5
th
 lap). 
6MWT: 6-minute walk test; TGlittre: Glittre-ADL test; IQR: interquartile range; SBP: systolic blood 
pressure; DBP: diastolic blood pressure; RR: respiratory rate; VT: tidal volume; VE: minute ventilation; 
VO2: oxygen uptake; VCO2: carbon dioxide output; VE/VO2: ventilatory equivalent for oxygen; VE/VCO2: 
ventilatory equivalent for carbon dioxide; RER: respiratory exchange ratio; HR: hear rate; MVV: maximal 
voluntary ventilation. p: significance level between tests (6MWT and TGlittre). 
 
The median time required to complete the TGlittre was 3.19 min (IQR [2,55-4,25]) and 
the median distance walked in the 6MWT was 492 m (IQR [440-561]). No correlation 
was found between LVEF and the time spent in TGlittre (r=0,42; p=0,19). There was a 
positive correlation between the time spent in TGlittre and the age of study population 
(r=0,89; p<0,01). We also find that the time spent in TGlittre was negatively correlated 
with distance walked in the 6MWT (r=-0,64, p=0,04) (Figure 2).  
 
 
Figure 2 – Correlation plot of 6-minute walk test (6MWT) distance and  
Glittre-ADL test (TGlittre) time. 
 
Analyzing the final VO2, we find a strong and positive correlation between CPET and 
TGlittre (r=0,72, p=0,01) and between 6MWT and TGlittre (r=0,67, p=0,02) (Figure 3). 
 
 
Figure 3 – Correlation plot of final VO2 between the 6-minute walk test (6MWT)  
and Glittre-ADL test (TGlittre). 
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When we analyze different variables of the physiological responses in both functional 
tests, and compare with CPET, we can observe that all results are submaximal (figure 
4). 
 
 
Figure 4 – Comparison between Heart Rate (HR), Minute Ventilation (VE),  
oxygen uptake (VO2) and respiratory exchange ratio (RER) of both submaximal tests (6 minute walk test 
and Glittre-ADL test) expressed as percentage of peak values at cardiopulmonary exercise test (CPET) 
performed by each patient.  
 
3. Discussion 
To the best of our knowledge, this is the first study describing cardiac, ventilatory and 
metabolic performance of TGlittre in HF patients. The main finding of our study is that 
TGlittre led to higher ventilatory and cardiovascular responses, but similar oxygen 
uptake compared to 6MWT.  
A previous study with COPD patients reported that TGlittre led to a slightly 
higher oxygen uptake, but similar ventilatory and cardiovascular responses when 
compared to a 6MWT (Karloh, Karsten, Pissaia, Araujo, & Mayer, 2014). This 
discordance might be explained by the different nature of each disease such as COPD 
and HF, as well as the different clinical severity of the patients in that study, which 
enrolled patients mostly (72%) with a GOLD 3 and 4 classifications.  
In our study, we observed that TGlittre induced higher ventilatory and cardiac 
responses, probably due to the fact that involves a greater number of muscles groups 
and with different activities besides walking, such as climbing up and down stairs. 
80 80 
84 
72 
76 
94 
72 
83 
69 
84 
0
10
20
30
40
50
60
70
80
90
100
HR
%
 o
f 
p
ea
k
 e
x
er
ci
se
 p
ar
am
et
er
s 
at
 C
P
E
T
 
6MWT
TGlittre
VE VO2 RER VCO2 
These findings may suggest that this functional test can be more specific when we 
aimed to evaluate different ADLs in HF patients.  
Despite the significant difference in final RER between TGlittre and 6MWT, the 
RER remained below 1, indicating that both tests evaluated exercise capacity in aerobic 
conditions. This characteristic has already been reported in several studies regarding 
6MWT (Deboeck, Muylem, Vachiéry, & Naeije, 2014; Kervio, Ville, Leclercq, 
Daubert, & Carre, 2004). 
Heart failure patients are very heterogeneous. The name of this disease is an 
umbrella term that encompasses younger patients with severe left ventricle systolic 
dysfunction and elderly with preserved left ventricle systolic function. Comorbidities 
and the stage of the disease have significantly impact their functional capacity. The 
patients we studied, had predominantly reduced LVEF, but with mild functional 
capacity impairment, as 91% of them present NYHA I-II class. 
 Looking into LVEF, our study found no correlation with TGlittre time spent. 
However, a previous study showed a negative correlation between TGlittre and LVEF (r 
=-0.66) (YD Valadares, KS Corrêa, BO Silva et al., 2011). One of the reasons that may 
explain the difference is that the patients, who spent more time in TGlittre, were those 
with a LVEF lower than 25%. In our study, all patients had a LVEF higher than 25%.   
 In the present study our sample completed the TGlittre in 3.19 minutes, in 
agreement with a recent study that reports 3.24 minutes in individuals with 
cardiovascular diseases (Fernandes-Andrade et al., 2017). However, different results 
were presented in a study with HF patients, who took 6.30 minutes to complete TGlittre 
(YD Valadares, KS Corrêa, BO Silva et al., 2011). These results can be explained by 
the substantial difference in functional class, since that patients had NYHA III and IV 
class. 
6MWT is a functional test widely used in patients with HF, which has been 
shown to be reproducible, sensitive to rehabilitation programs and valid in the 
functional evaluation (Adnan, Mckellar, Appukutty, Sulaiman, & Hassan, 2011). 
TGlittre is more recent, it includes exercises such as sit and stand, walk, climb up-and-
down stairs and move objects with unsupported upper limbs. Therefore, the functional 
tests that include different activities with the upper and lower limbs allow to measure 
with more precision the limitations of the ADLs when compared with tests that include 
exclusively walking, such as 6MWT (Karloh et al., 2014; YD Valadares, KS Corrêa, 
BO Silva et al., 2011).  
Evaluation of ADLs is not a simple task, and patients are typically asked to fill 
out questionnaires about their daily activities, which do not always reflect their 
limitations (Forman et al., 2017). TGlittre tries to overcome this by bringing together a 
group of activities that integrate any ADLs. 
In our view, taking into account the differences in physiological responses and 
the design of the test, we suggest that TGlittre adds additional information to 6MWT 
and can be potentially used in clinical practice, helping to identify the limitations in 
ADLs of patients with HF. However, it is still necessary to prove TGlittre sensitivity to 
changes induced by interventions in rehabilitation programs.  
One of the major advantages in our study was that all patients performed a 
CPET to evaluate at which proportion of maximal physiological responses the both 
submaximal test were performed.  
A previous study with HF patients reported that 6MWT was a submaximal test, 
with a maximal VO2 between 80% and 90% of peak VO2, similar to what we had 
observed in our study (Kervio et al., 2004). Comparing the TGlittre with CPET, we did 
observe that the variables VE, VO2, VCO2 and RER in TGlittre are below 85%. These 
results prove the submaximal characteristics of TGlittre. 
Aged society is accelerating rapidly and is associated with a decline of motor 
function and ability to perform ADLs. A frequent consideration in the assessment of 
functional capacity is whether to perform maximal or submaximal testing in elderly 
people. Whereas functional capacity measured by maximal exercise test is the gold 
standard, it is not always readily available and often limited by orthopedic, neurological 
or excessive cardiovascular risks in older adults (Arena et al., 2007). In turn, 
submaximal tests are more accessible and with lower risks, and also represent important 
measures of functional capacity that in many cases strongly determine an elderly person 
ability to remain independent (Forman, et al., 2017). 
The importance of using submaximal tests that evaluate and determine 
objectives for the accomplishment of ADLs in patients with HF should be emphasized, 
since such goals are more tangible and motivating for the patient than an abstract 
measure such as peak VO2. For that reason, rehabilitation programs should seek not 
only to increase maximal functional capacity but also the ability to perform ADLs, 
promoting independence and improvement in the quality of life (Forman, et al., 2017). 
In our opinion, physical therapists and physicians, together, need to assume a 
leadership role in developing new tests and measures, with the aimed of increasing the 
sensitivity as assessment and treatment outcome tools in different contexts. For 
instance, we consider that TGlittre has a great potential to provide valid indexes of a 
person’s capacity to perform ADLs. 
The following limitations of our study should be considered. The analysis of the 
comparison of CPET with submaximal tests should take into account the use of 
different indirect oximetry devices. Furthermore, the limited sample size should 
preclude the extrapolation of our results to other HF patients, particularly those with 
more severe functional impairment. Therefore, our results suggest that future studies 
aiming to look at TGlittre in HF should prioritize patients with more severe functional 
class impairment. 
 
4. Conclusion 
We describe for the first time the cardiac, ventilatory and metabolic performance 
of HF patients using TGlittre. In our sample, we observed difference ventilatory and 
cardiac responses compared to the widely used and validated 6MWT, despite similar 
metabolic profile. 
It seems plausible that this test opens a new perspective of global evaluation of 
individuals with HF and with the potential to become a valid and reliable method to 
portray functional performance in daily activities in this population. 
Our limited sample size, predominantly composed of HF patients with mild 
functional impairment, precludes a definite conclusion about the advantages of this new 
and promising submaximal test. 
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